PCI Pharma Services has announced a significant expansion of its Tredegar, Wales site, adding two new facilities for solid oral-dose manufacturing and packaging of highly potent drugs. The article gives no investment value or jobs figure.

Terumo Corporation approved a £33 million investment in its subsidiary Vascutek to expand its headquarters and manufacturing facility at Inchinnan, Renfrewshire, adding cleanrooms and a sterilization suite. The first phase starts April 2018 and completes in 2021.